Literature DB >> 26386341

Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.

Luisa Agnello1, Chiara Bellia1, Maria Di Gangi2, Bruna Lo Sasso1, Luca Calvaruso1, Giulia Bivona1, Concetta Scazzone1, Piera Dones2, Marcello Ciaccio3.   

Abstract

OBJECTIVES: Although the importance of serum Procalcitonin (PCT) levels at diagnosis is well established in adult Community-Acquired Pneumonia (CAP), its use remains controversial in pediatric CAP. The aim of our study is to investigate the role of PCT and C-Reactive Protein (CRP) in the assessment of pediatric CAP severity defined by the extent of consolidation on chest X-rays and the presence of pleural effusion. In this particular setting, no clinical severity score is available at present and chest X-ray, although important for diagnosis confirmation, is not recommended as routine test. DESIGN AND METHODS: The study involved 119 children admitted to the Department of Pediatric Infectious Disease for radiographically documented CAP aged 1 year to 14 years, without chronic diseases. Baseline PCT, CRP and routine laboratory tests were performed on admission.
RESULTS: The median PCT (μg/L) and CRP (mg/L) were 0.11 (0.05–0.58) and 21.3 (4.2–48.1), respectively. PCT showed a good correlation with CRP, neutrophils and WBC (r = 0.538, P < 0.001; r = 0.377, P < 0.001; r = 0.285, P0.002, respectively). CRP, but not PCT, was associated with lobar consolidation (P = 0.007) and pleural effusion (P = 0.002). Logistic regression analysis revealed that only CRP was a predictor of lobar consolidation (OR: 1.078; 95% CI: 1.017–1.143; P = 0.011) and pleural effusion (OR: 1.076; 95% CI: 1.005–1.153; P = 0.036).
CONCLUSION: Our findings revealed that PCT is correlated to the main inflammatory markers in children with CAP. CRP, unlike PCT, is able to predict the extent of chest X-ray infiltration and ultimately the severity of the disease confirming its usefulness in the management of pneumonia

Entities:  

Keywords:  CRP; Lobar consolidation; Pediatric community-acquired pneumonia; Pleural effusion; Pneumococcal; Procalcitonin; Severity

Mesh:

Substances:

Year:  2015        PMID: 26386341     DOI: 10.1016/j.clinbiochem.2015.09.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  16 in total

1.  Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia.

Authors:  Todd A Florin; Lilliam Ambroggio; Cole Brokamp; Yin Zhang; Mantosh Rattan; Eric Crotty; Michael A Belsky; Sara Krueger; Thomas N Epperson; Andrea Kachelmeyer; Richard Ruddy; Samir S Shah
Journal:  Pediatrics       Date:  2020-05-13       Impact factor: 7.124

2.  Comparison of Procalcitonin Guidance-Administered Antibiotics with Standard Guidelines on Antibiotic Therapy in Children with Lower Respiratory Tract Infections: A Retrospective Study in China.

Authors:  Guo Wu; Gao Wu; Shuxie Wu; Hanbin Wu
Journal:  Med Princ Pract       Date:  2017-06-01       Impact factor: 1.927

Review 3.  Vitamin D and Genetic Susceptibility to Multiple Sclerosis.

Authors:  Concetta Scazzone; Luisa Agnello; Giulia Bivona; Bruna Lo Sasso; Marcello Ciaccio
Journal:  Biochem Genet       Date:  2020-11-07       Impact factor: 1.890

4.  Correlations between Serum P2X7, Vitamin A, 25-hydroxy Vitamin D, and Mycoplasma Pneumoniae Pneumonia.

Authors:  Fanjun Meng; Ping Chen; Xiaolong Guo; Xiaoru Li; Yuexuan Wu; Wenen Liu; Feng Jiang; Huan Liu; Lixin Wang
Journal:  J Clin Lab Anal       Date:  2021-03-16       Impact factor: 2.352

5.  Role of procalcitonin in diagnosis of community acquired pneumonia in Children.

Authors:  Vinod H Ratageri; Puspha Panigatti; Aparna Mukherjee; Rashmi R Das; Jagdish Prasad Goyal; Javeed Iqbal Bhat; Bhadresh Vyas; Rakesh Lodha; Deepak Singhal; Prawin Kumar; Kuldeep Singh; Samarendra Mahapatro; Bashir Ahmad Charoo; S K Kabra; K R Jat
Journal:  BMC Pediatr       Date:  2022-04-20       Impact factor: 2.567

6.  Dual-Quantum-Dots-Labeled Lateral Flow Strip Rapidly Quantifies Procalcitonin and C-reactive Protein.

Authors:  XiaoPing Qi; YunYe Huang; ZhongShi Lin; Liang Xu; Hao Yu
Journal:  Nanoscale Res Lett       Date:  2016-03-25       Impact factor: 4.703

7.  Valuable hematological indicators for the diagnosis and severity assessment of Chinese children with community-acquired pneumonia: Prealbumin.

Authors:  Jingjing Ning; Xiaonan Shao; Yibo Ma; Darong Lv
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

8.  Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia.

Authors:  Susanna Esposito; Maria Di Gangi; Fabio Cardinale; Eugenio Baraldi; Ilaria Corsini; Liviana Da Dalt; Pier Angelo Tovo; Antonio Correra; Alberto Villani; Oliviero Sacco; Laura Tenero; Piera Dones; Monia Gambino; Alberto Zampiero; Nicola Principi
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

Review 9.  Prognostic scores and biomarkers for pediatric community-acquired pneumonia: how far have we come?

Authors:  Samuel N Uwaezuoke; Adaeze C Ayuk
Journal:  Pediatric Health Med Ther       Date:  2017-02-20

10.  Defining Pneumonia Severity in Children: A Delphi Study.

Authors:  Preston Dean; Daniel Schumacher; Todd A Florin
Journal:  Pediatr Emerg Care       Date:  2021-12-01       Impact factor: 1.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.